TrialFrontiers in endocrinology2026

Dermatologic outcomes associated with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a large-scale target trial emulation.

Yi-Lun Chiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.